DPU
DePuy Orthopaedics, Inc.
NASDAQ · Industrials · Specialty Business Services · CN
$1.70
−9.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.5M | 1.1M | 3.8M | 5.4M | 3.1M |
| Cost of Revenue | 9.8M | 1.0M | 2.4M | 1.9M | 957.1K |
| Gross Profit | 720.4K | 85.7K | 1.3M | 3.6M | 2.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 43.5M | 3.5M | 5.4M | 6.0M | 3.1M |
| General & Admin Expense | 42.9M | — | 5.0M | 4.8M | 2.1M |
| Selling & Marketing Expense | 236.5K | — | 397.6K | 2.5M | 948.6K |
| Other Expenses | — | — | 3.1M | 79.4K | — |
| Total Operating Expenses | 43.5M | 3.5M | 8.5M | 6.1M | 3.1M |
| Cost and Expenses | 53.3M | 4.5M | 10.9M | 7.9M | 4.0M |
| Operating Income (EBIT) | (42.8M) | (3.4M) | (7.1M) | (2.5M) | (919.8K) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 2.0M | 31.0K | (962.1K) | 50.1K | 27.2K |
| Non-Operating Income (excl Interest) | — | — | (3.0M) | — | — |
| EBT (Pre-Tax Income) | (40.8M) | (3.3M) | (8.1M) | (2.4M) | (892.6K) |
| Income Tax Expense | — | — | 54.5K | 115.1K | (121.1K) |
| Bottom Line | |||||
| Net Income | (40.5M) | (3.3M) | (8.7M) | (2.5M) | (771.5K) |
| Earnings from Cont. Ops | (40.8M) | (3.3M) | (8.1M) | (2.6M) | (771.5K) |
| Earnings from Discont. Ops | 291.4K | — | (532.7K) | 4.6K | — |
| Bottom Line Net Income | (40.8M) | (3.3M) | (8.1M) | (2.5M) | (771.5K) |
| Per Share | |||||
| Basic EPS | ($21.82) | ($3.74) | ($10.05) | ($0.61) | ($0.19) |
| Diluted EPS | ($21.82) | ($3.74) | ($10.05) | ($0.61) | ($0.19) |
| Revenue Per Share | $4.18 | $1.25 | $6.36 | $9.23 | $5.29 |
| Shares | |||||
| Basic Shares Outstanding | 2.5M | 892314 | 590000 | 590000 | 590000 |
| Diluted Shares Outstanding | 2.5M | 892314 | 590000 | 590000 | 590000 |
| Profitability Metrics | |||||
| EBITDA | (42.8M) | (3.4M) | (4.1M) | (2.4M) | (855.1K) |
| D&A | 42.2K | 11.7K | 89.4K | 77.5K | 64.7K |
| EBIT | (42.8M) | (3.4M) | (4.2M) | (2.5M) | (919.8K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026